Resultados de la búsqueda 291-300 of 9722 for stem cell

  1. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Adipose-Derived Mesenchymal Stem Cells (AMSCs) For Recurrent Glioblastoma. Jacksonville, Fla. This study aims to evaluate the safety of local delivery of AMSCs ...

  2. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Cabozantinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Immunotherapy with monoclonal antibodies, such as ...

  3. Neurología - Ensayos clínicos - Mayo Clinic

    Adipose-Derived Mesenchymal Stem Cells (AMSCs) For Recurrent Glioblastoma. Jacksonville, Fla. This study aims to evaluate the safety of local delivery of ...

  4. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The chimeric antigen receptor (CAR) T-cell therapy is a revolutionary cellular immunotherapy strategy that has transformed the treatment of B cell ...

  5. Ensayos clínicos - Neurología

    The study will optimize the development of skeletal muscle cells from patient induced pluripotent stem cells (iPSCs) and to characterize their morphological, ...

  6. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The chimeric antigen receptor (CAR) T-cell therapy is a revolutionary cellular immunotherapy strategy that has transformed the treatment of B cell ...

  7. Esclerosis lateral amiotrófica - Atención en Mayo Clinic

    ALS Stem Cell Trial · Gen de la esclerosis lateral amiotrófica. Procedimientos asociados. Análisis de orina · Electromiografía · Nutrición entérica en el hogar ...

  8. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The chimeric antigen receptor (CAR) T-cell therapy is a revolutionary cellular immunotherapy strategy that has transformed the treatment of B cell ...

  9. Neurología - Ensayos clínicos - Mayo Clinic

    Adipose-Derived Mesenchymal Stem Cells (AMSCs) For Recurrent Glioblastoma. Jacksonville, Fla. This study aims to evaluate the safety of local delivery of ...

  10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The chimeric antigen receptor (CAR) T-cell therapy is a revolutionary cellular immunotherapy strategy that has transformed the treatment of B cell ...